SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-21-021077
Filing Date
2021-04-12
Accepted
2021-04-09 17:34:33
Documents
10

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs12021a2_orionbiotech.htm S-1/A 3129694
2 OPINION OF KIRKLAND & ELLIS LLP fs12021a2ex5-1_orionbiotech.htm EX-5.1 24192
3 OPINION OF MAPLES AND CALDER, CAYMAN ISLANDS COUNSEL TO THE REGISTRANT fs12021a2ex5-2_orionbiotech.htm EX-5.2 51687
4 FORM OF FORWARD PURCHASE AGREEMENT BETWEEN THE REGISTRANT AND PURCHASER fs12021a2ex10-9_orionbiotech.htm EX-10.9 125145
5 CONSENT OF WITHUMSMITH+BROWN, PC. fs12021a2ex23-1_orionbiotech.htm EX-23.1 2559
6 CONSENT OF DIRECTOR NOMINEE - LOUISA RODRIGUEZ fs12021a2ex99-3_orionbiotech.htm EX-99.3 2762
7 GRAPHIC ex5-2_001.jpg GRAPHIC 2900
8 GRAPHIC ex5-2_002.jpg GRAPHIC 4184
9 GRAPHIC ex5-1_001.jpg GRAPHIC 3893
10 GRAPHIC ex5-1_002.jpg GRAPHIC 2215
  Complete submission text file 0001213900-21-021077.txt   3355719
Mailing Address 645 FIFTH AVENUE, 21ST FLOOR NEW YORK NY 10022
Business Address 645 FIFTH AVENUE, 21ST FLOOR NEW YORK NY 10022 212-303-7822
Orion Biotech Opportunities Corp. (Filer) CIK: 0001847416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-253548 | Film No.: 21818681
SIC: 6770 Blank Checks